Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 334-344

  Viola, Giampietro ^a   Salvador, Alessia ^a   Vedaldi, Daniela ^a   Dall'Acqua, Francesco ^a   Bianchi, Nicoletta ^b   Zuccato, Cristina ^b   Borgatti, Monica ^b   Lampronti, Ilaria ^b   Gambari, Roberto ^b,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Biotechnology Center   (Italy)

Author keywords

Apoptosis; Cell cycle; Erythroid differentiation; Erythroid precursors; K562 cells; Psoralens

Indexed keywords

4,4',6 TRIMETHYLANGELICIN; ALLOPSORALEN; ANGELICIN; BERGAPTEN; DNA; METHOXSALEN; PSORALEN; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; BETA THALASSEMIA; CANCER RISK; CELL CYCLE; CELL DIFFERENTIATION; CONFERENCE PAPER; CROSS LINKING; DRUG ACTIVITY; DRUG STRUCTURE; ERYTHROID CELL; FLOW CYTOMETRY; GENOTOXICITY; HEMATOLOGIC DISEASE; HUMAN; NONHUMAN; SICKLE CELL ANEMIA; SKIN CANCER; ULTRAVIOLET A RADIATION;

EID: 69149101948     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04894.x     Document Type: Conference Paper

References (65)

1. Dall'Acqua, F., G. Viola D. Vedaldi. 2004. Cellular and molecular target of psoralen. In CRC Handbook of Organic Photochemistry and Photobiology. W.M. Hoorspool & F. Lenci, Eds. : 1 17. CRC Press. Boca Raton, FL.
2. Parrish, J.A. et al. 1974. Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N. Engl. J. Med. 291 : 1207 1211.
3. Edelson, R. et al. 1987. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N. Engl. J. Med. 316 : 297 303.
4. Gollnick, H.P. et al. 1993. Unresponsive and severe generalized pemphigo vulgaris successfully controlled by extracorporeal photopheresis. J. Acad. Dermatol. 28 : 122 124.
5. Prinz, B., F. Nachbar G. Plewig. 1994. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch. Dermatol. Res. 287 : 48 52.
6. Bisaccia, E. et al. 1993. Extracorporeal photopheresis in the treatment of AIDS-related complex: extended trial. J. Acquir. Immune Defic. Syndr. 6 : 386 392.
7. Malawista, S.H., D.H. Trock R.L. Edelson. 1991. Treatment of rheumatoid arthritis by extracorporeal photopheresis. Arthritis Rheum. 34 : 646 654.
8. Knobler, R.M. 1994. Extracorporeal photochemotherapy for the treatment of lupus erythematosus: preliminary observations. Springer Semin. Immunopathol. 16 : 323 325.
9. Lin, L. et al. 1997. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of novel psoralen and long-wavelength ultraviolet light. Transfusion 37 : 423 435.
10. Ben-Hur, E. B. Horowitz. 1996. Virus inactivation in blood. AIDS 10 : 1183 1190.
11. Margolis-Nunno, H.L. et al. 1994. Quencher-enhanced specificity of psoralen photosensitized virus inactivation in platelet concentrates. Transfusion 34 : 802 810.
12. Margolis-Nunno, H.L. et al. 1997. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo. Transfusion 37 : 889 895.
13. Eble, B.E. L. Corash. 1996. Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: a model of surrogate human hepatitis B virus infectivity. Transfusion 36 : 406 418.
14. + channels: Synthesis and photoreactivity. J. Med. Chem. 41 : 4542 4549.
15. Vennekamp, J. et al. 2004. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 65 : 1364 1374.
16. Curini, M. et al. 2006. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr. Med. Chem. 13 : 199 122.
17. Santana, L. et al. 2004. Furocoumarins in medicinal chemistry. Synthesis, natural occurrence and biological activity. Curr. Med. Chem. 11 : 3239 3261.
18. Naldi, L. C.E. Griffiths. 2005. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br. J. Dermatol. 152 : 597 615.
19. Okamoto, T., T. Kobayashi S Yoshida. 2005. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr. Med. Chem. Anticancer Agents 5 : 47 51.
20. McNeely, W. K.L. Goa. 1998. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo. Drugs 56 : 667 690.
21. Scheinfeld, N. V. Deleo. 2003. A review of studies that have utilized different combinations of psoralen and ultraviolet B phototherapy and ultraviolet A phototherapy. Dermatol. Online J. 9 : 7.
22. McGinnis, K.S. et al. 2003. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: an effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Arch. Dermatol. 139 : 771 705.
23. Zarebska, Z. et al. 2000. PUVA (psoralen + UVA) photochemotherapy: processes triggered in the cells. Farmaco 55 : 515 520.
24. Stolk, L.M. A.H. Siddiqui. 1988. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens. Gen. Pharmacol. 19 : 649 653.
25. Dalla Via, L. et al. 1999. New tetracyclic analogues of photochemotherapeutic drugs 5-MOP and 8-MOP: synthesis, DNA interaction, and antiproliferative activity. J. Med. Chem. 42 : 4405 4413.
26. Gia, O. et al. 1996. 4′-Methyl derivatives of 5-MOP and 5-MOA: synthesis, photoreactivity, and photobiological activity. J. Med. Chem. 39 : 4489 4496.
27. Chilin, A. et al. 1999. Synthesis and biological activity of (hydroxymethyl)- and (diethylaminomethyl)benzopsoralens. J. Med. Chem. 42 : 2936 2945.
28. Dalla Via, L. et al. 2007. New furan side tetracyclic allopsoralen derivatives: synthesis and photobiological evaluation. J. Med. Chem. 49 : 4317 4326.
29. Caffieri, S. 2001. Reversed-phase high-performance liquid chromatography (RP-HPLC) determination of lipophilicity of furocoumarins: relationship with DNA interaction. J. Pharm. Sci. 90 : 732 739.
30. Bordin, F., F. Dall'Acqua A. Guiotto. 1991. Angelicins, angular analogs of psoralens: chemistry, photochemical, photobiological and photochemotherapeutic properties. Pharmacol. Ther. 52 : 331 363.
31. Bordin, F. et al. 1998. Photobiological properties of 1′-thieno-4,6,4′-trimethylangelicin. Photochem. Photobiol. 68 : 157 163.
32. Fossa, P. et al. 2002. Novel angular furo and thieno-quinolinones: synthesis and preliminary photobiological studies. Bioorg. Med. Chem. 10 : 743 751.
33. 2/M in the absence of p16(INK4a) p21(CIP1) or p53. Exp. Dermatol. 12 : 629 657.
34. Wlaschek, M. et al. 2003. Photoaging as a consequence of natural and therapeutic ultraviolet irradiation - studies on PUVA-induced senescence-like growth arrest of human dermal fibroblasts. Exp. Gerontol. 38 : 1265 1270.
35. Viola, G. et al. 2004. Differential response of linear and angular psoralen in PUVA-induced apoptosis in HL-60 cells. Photochem. Photobiol. Sci. 3 : 237 239.
36. 2/M cell cycle arrest in Karpas 299 T-lymphoma cells. J. Photochem. Photobiol. B 85 : 39 48.
37. Viola, G. et al. 2007. Caspase and mitochondrial dysfunction dependent mechanism of induced apoptosis by photoexcited psoralen derivatives in human lymphocytes. Toxicol. In Vitro 21 : 211 216.
38. Viola, G. et al. 2008. Central role of p53 and mitochondrial damage in PUVA-induced apoptosis in human keratinocytes. Toxicol. Appl. Pharmacol. 227 : 84 96.
39. Joerges, C. et al. 2003. Induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene 22 : 6119 6128.
40. Martelli, A.M. et al. 2004. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes. Haematologica 89 : 471 479.
41. Cappellini, A. et al. 2005. Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. Apoptosis 10 : 141 152.
42. Coven, T.R. et al. 1999. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol. Photoimmunol. Photomed. 15 : 22 27.
43. Canton, M. et al. 2002. PUVA-induced apoptosis involves mitochondrial dysfunction caused by the opening of the permeability transition pore. FEBS Lett. 522 : 168 172.
44. Santamaria, A.B. et al. 2002. p53 and Fas ligand are required for psoralen and UVA induced apoptosis in mouse epidermal cells. Cell Death Differ. 9 : 549 560.
45. Efferth, T., U. Fabry R. Osieka. 2001. Induction of apoptosis, depletion of glutathione, and DNA damage by extracorporeal photochemotherapy and psoralen with exposure to UV light in vitro. Anticancer Res. 21 : 2777 2783.
46. Lozzio, C.B. B.B. Lozzio. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45 : 321 334.
47. Gambari, R. E. Fibach. 2007. Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. Curr. Med. Chem. 14 : 199 212.
48. Lampronti, I. et al. 2003. Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin. Eur. J. Haematol. 71 : 189 195.
49. Fibach, E. et al. 1993. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Blood 82 : 2203 2209.
50. Perrine, S.P. et al. 1993. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N. Engl. J. Med. 328 : 81 86.
51. Rodgers, G.P. et al. 1993. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N. Engl. J. Med. 328 : 73 80.
52. Rodgers, G.P. E.A. Rachmilewitz. 1995. Novel treatment options in the severe beta-globin disorder. Br. J. Haematol. 91 : 263 268.
53. Steinberg, M.H. et al. 1997. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 89 : 1078 1088.
54. Olivieri, N.F. et al. 1998. Elimination of transfusion through induction of fetal hemoglobin synthesis in Cooley's anemia. Ann. N. Y. Acad. Sci. 850 : 100 109.
55. Viola, G. et al. 2008. Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocoumarin derivatives. Biochem. Pharmacol. 75 : 810 825.
56. Fibach, E. et al. 2003. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 102 : 1276 1281.
57. Potapenko, A.Y. 1991. Mechanism of photodynamic effects of furocoumarins. J. Photochem. Photobiol. B 9 : 1 33.
58. Mizuno, N. et al. Structural elucidation of the 8-methoxypsoralen oxidized product that inhibits the chemotactic activity of polymorphonuclear neutrophils toward anaphylatoxin C5a. Photochem. Photobiol. 54 : 697 701.
59. Esaki, K. N. Mizuno. 1992. Effect of psoralens + ultraviolet-A on the chemotactic activity of polymorphonuclear neutrophils towards anaphylatoxin C5a des Ag. Photochem. Photobiol. 55 : 783 788.
60. Kyagova, A.A. et al. 1991. Psoralen-photosensitised damage of rat peritoneal exudate cells. Photochem. Photobiol. 53 : 633 637.
61. Potapenko, A.Y. et al. 1994. Products of psoralen photooxidation possess immunomodulative and antileukemic effects. Photochem. Photobiol. 60 : 171 174.
62. Kagoya, A.A. et al. 1997. Suppression of delayed-type hypersensitivity and hemolysis induced by previously photooxidized psoralen: effect of fluence rate and psoralen concentration. Photochem. Photobiol. 65 : 694 700.
63. Lysenko, P.E. et al. 2000. Effect of glutathione peroxidase and catalase on hemolysis and methemoglobin modifications induced by photooxidized psoralen. J. Photochem. Photobiol. B 56 : 187 195.
64. Caffieri, S. et al. 2007. The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy. Blood 109 : 4988 4994.
65. Viola, G. et al. 2008. Furocoumarins photolysis products induce differentiation of human erythroid cells. J. Photochem. Photobiol. B 92 : 24 28.